14-day Premium Trial Subscription Try For FreeTry Free
$0.0545
-0.0026 (-4.47%)
At Close: Apr 16, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0481 $0.0700 Tuesday, 16th Apr 2024 BLPH stock ended at $0.0545. This is 4.47% less than the trading day before Monday, 15th Apr 2024. During the day the stock fluctuated 5.55% from a day low at $0.0541 to a day high of $0.0571.
90 days $0.0456 $0.0785
52 weeks $0.0290 $11.15

Historical Bellerophon Therapeutics prices

Date Open High Low Close Volume
2023-12-27 $0.0300 $0.0333 $0.0300 $0.0310 279 967
2023-12-26 $0.0326 $0.0333 $0.0320 $0.0330 99 471
2023-12-22 $0.0300 $0.0350 $0.0300 $0.0350 57 291
2023-12-21 $0.0321 $0.0353 $0.0320 $0.0320 86 733
2023-12-20 $0.0323 $0.0340 $0.0300 $0.0321 233 786
2023-12-19 $0.0325 $0.0340 $0.0323 $0.0323 128 253
2023-12-18 $0.0335 $0.0340 $0.0325 $0.0325 252 234
2023-12-15 $0.0335 $0.0370 $0.0335 $0.0370 161 932
2023-12-14 $0.0325 $0.0364 $0.0325 $0.0336 12 404
2023-12-13 $0.0368 $0.0368 $0.0336 $0.0336 2 650
2023-12-12 $0.0325 $0.0380 $0.0325 $0.0380 4 505
2023-12-11 $0.0384 $0.0419 $0.0328 $0.0328 38 848
2023-12-08 $0.0321 $0.0400 $0.0321 $0.0370 18 227
2023-12-07 $0.0363 $0.0375 $0.0321 $0.0362 39 737
2023-12-06 $0.0312 $0.0450 $0.0310 $0.0330 41 159
2023-12-05 $0.0340 $0.0390 $0.0340 $0.0360 48 775
2023-12-04 $0.0355 $0.0355 $0.0330 $0.0342 63 447
2023-12-01 $0.0330 $0.0370 $0.0330 $0.0355 176 835
2023-11-30 $0.0370 $0.0370 $0.0330 $0.0339 22 274
2023-11-29 $0.0330 $0.0364 $0.0330 $0.0364 11 662
2023-11-28 $0.0380 $0.0380 $0.0330 $0.0336 14 605
2023-11-27 $0.0350 $0.0390 $0.0330 $0.0330 8 824
2023-11-24 $0.0355 $0.0380 $0.0350 $0.0350 8 727
2023-11-22 $0.0330 $0.0400 $0.0330 $0.0330 72 306
2023-11-21 $0.0325 $0.0372 $0.0325 $0.0330 51 602
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Golden Star

Ticker Date Change Price
LXP Apr 05 0.790% $8.86
AKR Apr 05 4.23% $16.53
SARK Mar 28 12.46% $26.88
ARCC Mar 25 0.596% $20.12
STT Mar 19 3.18% $72.62
GGB Mar 19 4.45% $4.27
LNC Mar 18 2.61% $27.17
CAG Mar 18 5.46% $28.22
CMC Mar 14 4.83% $53.19
MASI Mar 14 4.47% $132.20
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT